Skip to main content

Menopause · Skin/hair

Facial Hair in Menopause: Why Chin Hairs Appear and What Actually Helps

Educational guide · By ClearHormones Editorial Team · Updated July 2026

Facial hair in menopause — coarse, dark strands on the chin, upper lip, or jawline — usually reflects a shift in the balance between estrogen and androgens, not a flood of new "male hormones." As estrogen falls during and after the menopause transition, the androgens your body has always produced become relatively more influential, and some facial follicles respond by growing thicker, darker, more visible hair. For most women this is a benign cosmetic change that can be managed. But the American College of Obstetricians and Gynecologists (ACOG) notes that coarse hair growing in a male-like pattern — called hirsutism — can sometimes reflect polycystic ovary syndrome (PCOS) or another condition, so hair that appears suddenly or is severe deserves evaluation.

The short answer

This page explains why the change happens, how a clinician distinguishes ordinary midlife facial hair from hirsutism that needs a workup, the cosmetic and medical options that genuinely exist, and how their costs are structured rather than guessing at dollar figures. It also flags the specific situations that warrant a prompt visit rather than watchful waiting.

One thing to set aside early: menopausal hormone therapy is prescribed for symptoms like hot flashes and vaginal dryness — it is not a facial-hair treatment — and over-the-counter "hormone" creams sold online are not an FDA-approved answer. The paths with real evidence run through cosmetic hair removal and, where appropriate, prescription medicines a clinician selects for you.

Why facial hair becomes more noticeable in menopause

The menopause transition is defined by changing cycle patterns over time rather than a single lab value — the framework clinicians use, the Stages of Reproductive Aging Workshop (STRAW+10), stages this shift by menstrual pattern. Across that transition, estrogen production from the ovaries declines and eventually stays low after the final period.

Androgens — hormones like testosterone that everyone produces — do not necessarily climb during this time. What changes is the ratio: as estrogen falls, the androgens already present become relatively more dominant, and hair follicles on the face that are sensitive to them can respond. This is why the change can feel abrupt even when your overall hormone levels are simply rebalancing.

At the follicle, the visible result is a conversion from fine, pale vellus hair to coarser, darker terminal hair in areas like the chin, upper lip, and jaw. The follicle count does not increase; existing follicles start producing more prominent strands. That distinction matters, because management is about changing how those follicles behave or removing the hair they produce.

ACOG frames the midlife version plainly: the fall in estrogen relative to androgens can make facial hair more noticeable. For many women this is the whole story — a cosmetic nuisance rather than a sign of disease.

Hirsutism versus ordinary midlife facial hair

Not all facial hair is hirsutism. Fine vellus hair covers most of the face and is normal. Hirsutism, as ACOG defines it, is the growth of coarse, dark hair in a male-like pattern — think the chin, upper lip, chest, or lower abdomen — driven by androgen activity at the follicle.

The pattern and pace are what a clinician weighs. A few coarse chin hairs that emerge gradually over the menopause years sit at the mild, common end of the spectrum. Hair that spreads across classically androgen-dependent areas, or that thickens quickly over months, sits at the end that prompts a closer look.

This distinction is useful before you spend money on treatment. Isolated, slowly appearing hairs are usually a cosmetic decision. A broader, faster, or newly appearing pattern is a medical question first — because treating the appearance without checking the cause can miss something that matters.

When facial hair warrants evaluation

ACOG notes that hirsutism can reflect PCOS or other conditions, and that evaluation may be warranted — particularly when hair growth is sudden or severe. Rapid onset is the signal that most reliably separates a routine midlife change from one worth investigating.

Watch for hair growth that accompanies other androgen-related signs, sometimes called virilization: a deepening voice, thinning hair at the scalp in a male pattern, new acne, or increasing muscularity. Any of these alongside fast-growing coarse hair is a reason to be evaluated rather than to start home removal and wait.

Timing also matters. New, worsening coarse hair well after menopause, especially over a short window, is more likely to prompt a workup than gradual change during the transition. Bringing a clear timeline — when it started, how fast it changed, what else changed with it — makes the visit more productive.

A related red flag belongs in the same conversation for a different reason: any vaginal bleeding 12 or more months after your final period is postmenopausal bleeding, which ACOG says always needs evaluation. It is unrelated to hair itself, but it is the kind of finding never to minimize while you are already thinking about hormonal changes.

What a clinician evaluation involves

An evaluation typically starts with history and pattern: where the hair is, how fast it appeared, your menstrual history through the transition, medications, and family history. Much of the assessment is about distinguishing a gradual, benign pattern from one that changed quickly.

Depending on that picture, a clinician may examine androgen-sensitive areas and, when warranted, order blood tests to look for a hormonal cause such as PCOS or a less common source of excess androgen. The point of testing is not to treat a number but to decide whether the hair is a standalone cosmetic issue or a window into something that deserves its own management.

The value of this step is that it sets the direction. If the workup is reassuring, you are choosing among cosmetic and optional medical treatments purely for appearance. If it turns up an underlying condition, treating that condition becomes part of the plan — and may itself change the hair over time.

Cosmetic ways to manage facial hair

Cosmetic removal treats the hair you can see and is the right starting point for most women whose evaluation is reassuring. Shaving and dermaplaning cut hair at the surface; despite a persistent myth, they do not make regrowth thicker or darker — the blunt cut edge only feels coarser as it grows back.

Plucking, threading, and waxing remove hair from the follicle and suit a handful of scattered hairs or small areas, with results lasting until the follicle regrows. Depilatory creams dissolve hair at the surface but can irritate facial skin, so a patch test and cautious use on the face are sensible.

For longer-lasting reduction, laser hair reduction targets pigment in the follicle and tends to work best on dark hair against lighter skin, though device options have widened; it reduces rather than guarantees permanent removal and usually needs a series plus maintenance. Electrolysis treats one follicle at a time and is the method described as permanent, working across hair colors but requiring many sessions.

None of these change the hormonal balance driving the hair, which is why they are ongoing choices. That is not a drawback so much as a fit question: light upkeep methods for a few hairs, energy-based methods when you want to reduce density over the long run.

Comparing the main options

The table below lays out how the common approaches differ in mechanism, fit, access, and cost structure. It avoids specific prices because they vary widely by provider, region, and — for prescriptions — insurance; what is reliable is the shape of the cost, not a headline number.

Use it to narrow the field before a visit: cosmetic methods you can begin on your own, energy-based methods that need a qualified provider, and prescription routes that require a clinician's judgment about suitability.

How facial-hair management options compare (structure, not fixed prices)
OptionHow it worksBest suited forAccessCost structure
Shaving / dermaplaningCuts hair at the skin surfaceFast, low-effort upkeepAt home, OTCLow and recurring (tools/blades); does not thicken regrowth
Plucking / threading / waxingRemoves hair from the follicleA few scattered or patchy hairsAt home or salonPer session; salon adds a service fee
Depilatory creamsDissolve hair at the surfaceSmall areas, after a patch testOTCLow and recurring; facial irritation risk
Prescription topical that slows regrowthSlows facial hair regrowth over weeksAn adjunct, not permanent removalPrescriptionVaries by insurance, formulary, or cash; ongoing
Laser hair reductionTargets pigment in the follicleLonger-lasting density reductionLicensed clinic/providerSeries of sessions plus maintenance; largely out-of-pocket
ElectrolysisDestroys follicles individuallyThe method described as permanent; any hair colorLicensed electrologistMany per-session visits; out-of-pocket
Oral medicines (anti-androgen or combined hormonal contraception)Reduce androgen effect on folliclesHirsutism, under a clinician's guidancePrescription onlyInsurance, formulary, or cash; ongoing

Medical treatments a clinician may discuss

When facial hair is bothersome enough to warrant medication, or when a workup points to an androgen-driven cause, ACOG describes medical options alongside cosmetic ones. These lower how strongly androgens act on the follicle, so they work gradually and are chosen by a clinician against your full health picture.

Combined hormonal contraception — the pill, patch, or ring — is one such option in some people because it can lower androgen effect and regulate cycles. But ACOG notes real contraindications, including smoking at age 35 or older, certain cardiovascular risks, and migraine with aura, so a clinician determines suitability. It is worth being precise: this is contraception, not menopausal hormone therapy, and it is used here for its androgen-lowering and cycle effects.

Anti-androgen medicines are another prescription route ACOG describes for hirsutism, working by blunting androgen activity at the follicle. There is also a prescription topical that slows facial hair regrowth over weeks; it reduces rather than removes hair and is used as an adjunct, often alongside a cosmetic method. Because these medicines act slowly, results are measured over months, and any of them is a decision to make with a clinician rather than to source on your own.

Does menopausal hormone therapy help facial hair?

Menopausal hormone therapy (HT) is prescribed for menopausal symptoms — hot flashes, night sweats, and genitourinary symptoms like vaginal dryness — not as a treatment for facial hair. ACOG and the North American Menopause Society (NAMS, in its 2022 position statement) frame HT around those symptom indications and individual risk, not hirsutism.

There is a piece of HT that people sometimes confuse with hair treatment: endometrial protection. NAMS 2022 holds that a person with a uterus taking systemic estrogen needs an adequate progestogen to protect the uterine lining, and micronized progesterone is the FDA-approved oral progesterone used for that purpose. That protects the endometrium; it is not a plan for chin hairs.

So if you are considering HT, weigh it on its own merits for menopausal symptoms and discuss risks with a clinician — and treat facial hair as a separate question with its own cosmetic or prescription answers. Expecting HT to resolve hirsutism sets up disappointment; matching each therapy to what it actually does is the more useful frame.

OTC creams, supplements, and online sellers: the honest verdict

Start with the regulatory reality, because it saves money and risk. Over-the-counter "bioidentical progesterone creams" are not FDA-approved as hormone therapy; their absorption is variable, and they are not established to do the jobs real HT does — including protecting the endometrium. They are not a treatment for facial hair, and they are not a substitute for approved care.

Oral DHEA sold as a supplement sits in the same category: it is not an FDA-approved drug, and human evidence for menopause, anti-aging, or weight benefits is limited and unproven. The one prescription DHEA product with an FDA approval is vaginal prasterone (Intrarosa), and its label indication is moderate-to-severe painful sex due to menopause — not facial hair, and not a systemic hormone fix. Buying oral DHEA to influence hair or hormones is not supported by the evidence.

Be especially wary of online sellers marketing "hormone-balancing" creams, capsules, or peptides for facial hair or menopause. Products sold outside the regulated pharmacy channel can be mislabeled or counterfeit, and "balance your hormones" marketing is a signal to slow down, not to buy. If a product claims to do what an FDA-approved medicine does, without the approval, treat that as a reason to route through a clinician instead.

How the costs actually break down

Rather than a single price, think in cost structures. Cosmetic upkeep methods — shaving, plucking, threading, waxing, depilatory creams — are low per use but recurring, so the real cost is frequency over time. Salon services add a per-visit fee on top of the method itself.

Energy-based methods are structured as a series. Laser hair reduction is typically sold as a package of sessions with periodic maintenance, and electrolysis is billed per session across many visits; both are commonly out-of-pocket because they are considered cosmetic. The variable that moves total cost most is how many sessions your hair density and color require.

Prescription routes carry a different structure entirely: what you pay depends on your insurance coverage, the plan's formulary, and whether you use a cash or discount price when a medicine is not covered. Because these are ongoing medicines, the relevant figure is the recurring monthly cost under your specific plan, which a pharmacy can confirm. Across all of these, be skeptical of any seller quoting a flat, too-good price for a "permanent hormone cure" — the honest options are priced by sessions or by prescription, not by a one-time miracle fee.

Safe self-care between visits

While you decide on a longer-term approach, low-risk home methods are fine for a few hairs: shaving or dermaplaning for speed, or plucking and threading for precision. Keep tools clean, avoid over-plucking the same spot, and stop if skin becomes inflamed.

To limit ingrown hairs and irritation on the face, exfoliate gently, avoid dragging a dull razor, and give waxed or threaded skin time to calm before layering active skincare. If a depilatory cream is your choice, patch-test away from the face first, because facial skin reacts more readily.

None of this changes the underlying hormonal balance, and that is expected — home care manages appearance and comfort while the medical questions, if any, are sorted out with a clinician. If home methods are not keeping up, that is information worth bringing to a visit rather than a reason to escalate to unregulated products.

When to see a clinician

See a clinician promptly if facial hair appears suddenly or worsens quickly, especially with signs like a deepening voice, male-pattern scalp thinning, new acne, or increasing muscularity — ACOG flags sudden or severe hirsutism as warranting evaluation, since it can reflect PCOS or another condition.

Book a routine visit if the hair is gradual but bothersome and you want to discuss medical options, because prescription routes each have suitability rules — combined hormonal contraception, for instance, is not appropriate for everyone. A clinician can match a treatment to your health history.

Seek care without delay for any vaginal bleeding 12 or more months after your final period, or very heavy bleeding during the transition; ACOG says postmenopausal bleeding always needs evaluation. It is unrelated to hair, but it is never something to watch and wait on. When you are ready to explore prescription options, you can compare providers licensed in your state to find one who treats menopausal and androgen-related concerns.

Affiliate link Advertiser Disclosure: This site is reader-supported. We may earn an affiliate commission when you sign up for a service through links on our site. This does not influence our editorial recommendations or medical reviews. Read our full disclosure.

Frequently asked questions

Why am I suddenly getting chin hairs in menopause?
As estrogen falls during and after the menopause transition, the androgens your body already makes become relatively more dominant, and facial follicles can respond by growing coarser, darker hair. ACOG notes this fall in estrogen relative to androgens makes facial hair more noticeable. It usually reflects a rebalancing, not a surge of new hormones — but hair that appears suddenly or is severe is worth evaluating.
Is menopausal facial hair a sign of PCOS or something serious?
It can be. ACOG notes that hirsutism — coarse hair in a male-like pattern — can reflect PCOS or other conditions, so evaluation may be warranted, especially when growth is sudden or severe or comes with signs like a deepening voice. Gradual, isolated chin hairs during the transition are usually benign, but a fast-changing or spreading pattern is a medical question first.
Does shaving make facial hair grow back thicker?
No. Shaving and dermaplaning cut hair at the surface and do not change the follicle, so regrowth is not thicker or darker — the blunt cut edge simply feels coarser as it grows. Both are reasonable low-cost upkeep methods for a few hairs while you consider longer-term options.
Will hormone therapy get rid of my facial hair?
Menopausal hormone therapy is prescribed for symptoms like hot flashes and vaginal dryness, not as a facial-hair treatment, so it is not the right tool for hirsutism. If facial hair needs medication, ACOG describes options like anti-androgen medicines or combined hormonal contraception, chosen by a clinician. Treat HT and facial hair as separate decisions.
Are over-the-counter progesterone creams or DHEA supplements good for menopausal facial hair?
No. OTC progesterone creams are not FDA-approved as hormone therapy, their absorption is variable, and they are not a facial-hair treatment. Oral DHEA supplements are not FDA-approved drugs and lack proven human evidence for these uses. The only FDA-approved DHEA product, vaginal prasterone, is indicated for painful sex due to menopause — not hair. Route these questions through a clinician instead of online sellers.
What is the most permanent way to remove facial hair?
Electrolysis is the method described as permanent, treating one follicle at a time across any hair color, though it requires many sessions. Laser hair reduction offers longer-lasting reduction and works best on dark hair against lighter skin but usually needs a series plus maintenance. Neither changes the hormones driving the hair, so they manage appearance rather than the underlying cause.
How much does treating menopausal facial hair cost?
Costs are structured, not fixed. Cosmetic upkeep is low but recurring; laser and electrolysis are billed as multiple sessions and are usually out-of-pocket; prescription medicines cost whatever your insurance, formulary, or cash price sets, on an ongoing basis. Be skeptical of any seller quoting a flat price for a one-time "hormone cure" — the legitimate options are priced by sessions or prescriptions.
When should facial hair send me to a doctor right away?
See a clinician promptly if coarse hair appears or worsens quickly, particularly with a deepening voice, male-pattern scalp thinning, new acne, or increasing muscularity, since ACOG flags sudden or severe hirsutism for evaluation. Separately, seek care for any bleeding 12 or more months after your last period — postmenopausal bleeding always needs evaluation.

Primary sources

  1. ACOG, Hirsutism in Women
  2. ACOG, The Menopause Years
  3. ACOG, Hormone Therapy for Menopause
  4. ACOG, Combined Hormonal Birth Control: Pill, Patch, and Ring
  5. ACOG, Perimenopausal Bleeding and Bleeding After Menopause
  6. The 2022 hormone therapy position statement of NAMS. Menopause 2022. PMID 35797481.
  7. Stages of Reproductive Aging Workshop +10 (STRAW+10). PMID 22344196.
  8. FDA Prescribing Information, Intrarosa (prasterone / vaginal DHEA) vaginal insert

ClearHormones publishes editorial health information for education only — not medical advice.